Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ethyl 3 Hydroxy 4 Chlorobutyrate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113292426A details a high-yield methanol-based reduction process for ethyl 3-hydroxy-4-chlorobutyrate, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel synthesis method reduces cost and waste significantly. High yield 83-87% ensures efficiency. Reliable supply chain for pharmaceutical intermediates manufacturing.